Prescriber is the leading UK journal for healthcare professionals focussing on prescribing and medicines management. The journal features articles on all areas of therapeutics and prescribing policy and is fully peer reviewed. The content is relevant and of interest to all prescribers and prescribing policy makers including GPs, pharmacists, nurses and hospital specialists. Access to all content is free to healthcare professionals following registration.
Latest News
Rivaroxaban approved by NICE for secondary prevention of atherothrombotic events
NICE has published final technology appraisal guidance (TA607) recommending rivaroxaban (Xarelto), in combination with aspirin, for the prevention of...Read more
EMA recommends upadacitinib for rheumatoid arthritis
The EMA's Committee for Medicinal Products for Human Use (CHMP) has recommended a marketing authorisation for upadacitinib (Rinvoq) for the treatment of...Read more
CHMP reverses decision on romosozumab for osteoporosis
Following an initially negative opinion in June and subsequent re-examination of the data, the EMA’s Committee for Medicinal Products for Human Use (CHMP)...Read more
Esketamine nasal spray for treatment-resistant depression
The EMA's Committee for Medicinal Products for Human Use (CHMP) has recommended the granting of a marketing authorisation for esketamine nasal spray (Spravato)...Read more
Cystic fibrosis medicines now available on the NHS in England
NHS England has reached a commercial agreement with Vertex Pharmaceuticals to allow NHS patients in England access to all three of their cystic fibrosis...Read more
Featured Articles
Obsessive-compulsive disorder: current management options
Obsessive-compulsive disorder is a disabling condition that can severely affect daily activities in both adults and children. This article discusses the psychological and drug treatments available, and highlights instances where referral for specialised treatment is appropriate.
Click here to view
Prescribing Simulator: new tool to develop prescribing skills
Gaining sufficient expertise on medicines and prescribing takes practice, which is ideally done in an environment that doesn’t involve actual patients. This is the function of the recently launched Prescribing Simulator, an e-learning project from the British Pharmacological Society. This article takes a look at this new initiative, how it works and who might benefit.
Click here to view
Diagnosis and treatment of eczema in children
Eczema in children is usually of mild or moderate severity, but it can have a significant psychosocial impact and be challenging to treat. This article discusses the diagnosis and treatment of mild to moderate eczema in children, which can usually be effectively managed in primary care.
Click here to view
